Cargando…

Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis

INTRODUCTION: Azivudine has undergone a few randomized controlled trials (RCTs) as of late. This study aimed to assess the COVID-19 treatment with azvudine's efficacy and safety. METHODS: Through January 20, 2023, systematic searches of PubMed, Embase, ClinicalTrials.gov, International Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhaoyan, Tian, Fangyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559905/ https://www.ncbi.nlm.nih.gov/pubmed/37809649 http://dx.doi.org/10.1016/j.heliyon.2023.e20153

Ejemplares similares

Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Tian, Fangyuan, et al.
Publicado: (2023)

Efficacy and safety of tofacitinib for the treatment of chronic plaque psoriasis: a systematic review and meta-analysis
por: Tian, Fangyuan, et al.
Publicado: (2019)

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials
por: Zhu, Ke-Wei
Publicado: (2023)

Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study
por: Zhao, Qinqin, et al.
Publicado: (2023)

Efficacy of Nirmatrelvir-Ritonavir versus Azvudine for COVID-19 Treatment in Tibet: A Retrospective Study
por: Zhao, Xiang, et al.
Publicado: (2023)

Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19
por: Gao, Yuan, et al.
Publicado: (2023)

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020)

The first Chinese oral anti-COVID-19 drug Azvudine launched
por: Yu, Bin, et al.
Publicado: (2022)

Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine
por: Mao, Manyun, et al.
Publicado: (2023)

Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis
por: Tian, Fangyuan, et al.
Publicado: (2022)

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
por: Zhang, Xi, et al.
Publicado: (2023)

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study
por: Zong, Kaican, et al.
Publicado: (2023)

Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients
por: de Souza, Sávio Bastos, et al.
Publicado: (2023)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysis
por: Tian, Fangyuan, et al.
Publicado: (2022)

Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
por: Sun, Yuming, et al.
Publicado: (2023)

Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis
por: Zhao, Mengnan, et al.
Publicado: (2023)

Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis
por: Zhang, Lei, et al.
Publicado: (2022)

Prevalence of Use of Potentially Inappropriate Medications Among Older Adults Worldwide: A Systematic Review and Meta-Analysis
por: Tian, Fangyuan, et al.
Publicado: (2023)

Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)

Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis
por: Angamo, Mulugeta T., et al.
Publicado: (2021)

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
por: Zhang, Jin-Lan, et al.
Publicado: (2021)

Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Fei, Zhangcheng, et al.
Publicado: (2022)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Amani, Behnam, et al.
Publicado: (2021)

Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
por: Liu, Ming, et al.
Publicado: (2021)

Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
por: Mittal, Niti, et al.
Publicado: (2021)

Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis
por: Alhumaid, Saad, et al.
Publicado: (2020)

All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis
por: Chen, Ru, et al.
Publicado: (2023)

Efficacy and Safety of Convalescence Plasma Therapy in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Dai, Rongjuan, et al.
Publicado: (2022)

Safety and efficacy of mesenchymal stem cells in COVID‐19 patients: A systematic review and meta‐analysis
por: Yan, Cai, et al.
Publicado: (2023)

Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis
por: Calvache-Mateo, Andrés, et al.
Publicado: (2023)

Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis
por: Tian, Yan, et al.
Publicado: (2022)

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 –a systematic review and meta-analysis
por: Choudhuri, Anirban Hom, et al.
Publicado: (2021)

Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis
por: Sarma, Phulen, et al.
Publicado: (2020)

Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Cheng, Wenwen, et al.
Publicado: (2020)

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Pormohammad, Ali, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uncl35ad5t2eupbv0hi92kk2sd